Literature DB >> 19130323

An unusual case of smoldering AML with prolonged indolent clinical course and spontaneous remission in the terminal phase.

Dragomir Marisavljevic1, Olivera Markovic, Radmila Zivkovic.   

Abstract

An unusual case of acute myeloblastic leukemia (AML) with indolent clinical course and spontaneous remission in the terminal phase is described. A 63-year-old male has been diagnosed to suffer from AML, subtype M2. Chromosomal analysis showed 46,XY,del(6)(q21). Clinical course was slowly progressive ("smoldering" AML). The patient did not require cytoreductive drugs, and occasional supportive therapy was his only treatment. Five years from diagnosis patient exhibited spontaneous remission of the disease, accompanied with disappearance of del(6q) clone. Six months after, relapse occured and patient died from CNS bleeding. Additional curiosity in this case is the fact that patient's older brother died of acute lymphoblastic leukemia at the age of 71 years. Possible mechanisms of spontaneous remission of AML and genetic predisposition for human leukemia are discussed with a review of the literature.

Entities:  

Mesh:

Year:  2009        PMID: 19130323     DOI: 10.1007/s12032-008-9153-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  19 in total

1.  Spontaneous remission in a secondary acute myelogenous leukaemia following invasive pulmonary aspergillosis.

Authors:  A Tzankov; C Ludescher; H C Duba; M Steinlechner; R Knapp; T Schmid; K Grünewald; G Gastl; R Stauder
Journal:  Ann Hematol       Date:  2001-07       Impact factor: 3.673

2.  Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment.

Authors:  Nicolas Tsavaris; Petros Kopterides; Christos Kosmas; Marina Siakantaris; Evangelos Patsouris; Gerasimos Pangalis
Journal:  Leuk Lymphoma       Date:  2006-03

3.  Anticipation in familial leukemia.

Authors:  M Horwitz; E L Goode; G P Jarvik
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

4.  Spontaneous remission of acute myeloid leukemia after infection and blood transfusion associated with hypergammaglobulinaemia.

Authors:  M Mitterbauer; M Fritzer-Szekeres; G Mitterbauer; I Simonitsch; P Knöbl; C Rintelen; I Schwarzinger; O A Haas; K Silberbauer; K Frey; B Bibus; I Pabinger; T Radaszkiewicz; K Lechner; U Jaeger
Journal:  Ann Hematol       Date:  1996-10       Impact factor: 3.673

Review 5.  Deletion of chromosome 6q in two cases of acute myeloblastic leukemia and a review of the literature.

Authors:  J Hirata; Y Abe; F Taguchi; H Takatsuki; J Nishimura; H Nawata
Journal:  Cancer Genet Cytogenet       Date:  1992-02

6.  De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy.

Authors:  S Yoshida; K Kuriyama; Y Miyazaki; J Taguchi; T Fukushima; M Honda; T Hayashibara; K Nagai; S Atogami; K Toriya; H Soda; H Nonaka; S Momita; I Jinnai; T Amenomori; M Kusano; Y Yoshida; S Ikeda; T Matsuo; M Tomonaga
Journal:  Leuk Res       Date:  2001-01       Impact factor: 3.156

7.  Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience.

Authors:  J M Bennett; M L Young; J W Andersen; P A Cassileth; M S Tallman; E Paietta; P H Wiernik; J M Rowe
Journal:  Cancer       Date:  1997-12-01       Impact factor: 6.860

8.  Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapy.

Authors:  G Oberg; A Killander; M Björeman; G Gahrton; G Grimfors; A Gruber; R Hast; R Lerner; J Liliemark; S Mattson; C Paul; B Simonsson; A-M Stalfelt; L Stenke; U Tidefelt; A-M Udén; M Björkholm
Journal:  Eur J Haematol       Date:  2002-06       Impact factor: 2.997

9.  Acute myeloid leukemia in the elderly: a critical review of therapeutic approaches and appraisal of results of therapy.

Authors:  F Ferrara; S Mirto; V Zagonel; A Pinto
Journal:  Leuk Lymphoma       Date:  1998-04

Review 10.  Spontaneous remission in acute myeloid leukaemia.

Authors:  R Paul; K Remes; T Lakkala; T T Pelliniemi
Journal:  Br J Haematol       Date:  1994-01       Impact factor: 6.998

View more
  1 in total

1.  Intentional donor lymphocyte-induced limited acute graft-versus-host disease is essential for long-term survival of relapsed acute myeloid leukemia after allogeneic stem cell transplantation.

Authors:  Matthias Eefting; Peter A von dem Borne; Liesbeth C de Wreede; Constantijn J M Halkes; Sabina Kersting; Erik W A Marijt; Hendrik Veelken; Jh Frederik Falkenburg
Journal:  Haematologica       Date:  2013-11-15       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.